Navigation Links
James George, MD: 2012 ASH Wallace H. Coulter Award for Lifetime Achievement in Hematology
Date:8/27/2012

The Wallace H. Coulter Award for Lifetime Achievement in Hematology is bestowed on an individual who has demonstrated a lifetime commitment and made outstanding contributions to hematology, and who has made a significant impact on education, research, and practice. This award will be presented to Dr. George at 1:15 p.m. on Sunday, December 9, during the 54th ASH Annual Meeting and Exposition in Atlanta.

Dr. George, who holds the George Lynn Cross Research Professorship in the Departments of Medicine and Biostatistics & Epidemiology at OUHSC, is a pioneer in the field of platelet glycoproteins. His early research focused on the radiolabeling of platelet surface components and their analysis by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. Through these methods, in 1984 Dr. George and colleagues were able to describe the molecular basis of platelet function in hemostasis, one of his signature research achievements. Dr. George's original research is documented in more than 100 publications in peer-reviewed journals.

Dr. George's seminal work related to the diagnosis and clinical management of idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP) has shaped the field's modern understanding of platelet disorders. The cornerstone of Dr. George's current work in TTP is his initiation and maintenance of the Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry, which has led to an increase in clinical knowledge of this rare disorder. Since Dr. George created the registry of all patients with clinically diagnosed TTP or HUS in central-western Oklahoma in 1989, it has uncovered important insights regarding clinical presentations and outcomes, predictors of disease severity, and the role of ADAMTS13 testing in TTP-HUS. Registry data have led to numerous manuscripts in the scientific literature over the past 20 years which have included the participation of many stude
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
202-552-4927
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Medical Tourism: Uncharted Territory for Patients James Goldberg, Author of the American Medical Money Machine, Is Offering a New Consulting Service to Medical Patients Considering “Medical Tourism” Treatment
2. ASH awards Timothy J. Ley, M.D., with 2012 E. Donnall Thomas Lecture and Prize
3. IASLC awarded accreditation as continuing medical education provider
4. American College of Physicians awarded 3-year federal grant to increase adult immunization rates
5. IHME professor named first health measurement winner of prestigious innovation award
6. NIH awards $7.8 million for innovative HIV vaccine approaches
7. ACP physician wins national award for internal medicine education
8. Researchers awarded National Cancer Institute grants aimed at answering provocative questions
9. Crimmins earns GSAs 2012 Robert W. Kleemeier Award
10. Naylor earns GSAs 2012 Maxwell A. Pollack Award for Productive Aging
11. Beck earns GSAs 2012 M. Powell Lawton Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... ... For Dallas, the time is nearing for the annual Heart Walk, and ... The American Heart Association hosts their well-known Heart Walk to raise money in awareness ... can be made. Walkers can participate in the cause and someone can also donate, ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best Drug ... of the “Music With A Mission” benefit concert in Mendon, IL. Held in the ... raise money to support music education programs in the underfunded local school districts of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, Inc., the ... and data center assets and audio-video devices, recently released Visio Stencils for the ... HP ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... three-year accreditation for its adolescent residential, counseling, day treatment and intensive family based ... meets international standards for quality and its pursuit of excellence. As a nonprofit ...
(Date:8/28/2015)... Northridge, CA (PRWEB) , ... August 28, 2015 , ... ... special price on Zoom teeth whitening. For just $199, patients can currently receive a ... to traditional in-office teeth whitening procedures, but it includes a number of unique features ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... , , , , ... Cleveland Clinic Lou Ruvo Center for Brain Health welcomes ... highly touted model of patient-focused care. , , ... Health is a highly specialized clinical center designed to advance the research, early ...
... Va., July 13 Long term care costs in most ... putting significant financial pressure on those in or near retirement. ... Genworth offers a suite of insurance products to help people ... in Arkansas can take advantage of a new program designed ...
... , , , ... BMRN ) announced today that patient enrollment has been ... 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder ... company expects to report initial results in the first half of ...
... of lives, researchers say , MONDAY, July 13 (HealthDay ... have died because of safety restrictions on the ... study suggests. , Finnish researchers concluded that clozapine is ... antipsychotics. , For this study, the researchers looked at ...
... , LOS ALTOS, Calif., July 13 InteKrin ... as Chief Business Officer. Most recently, Mr. Parker served as ... Goldman, Sachs & Co. Over the past ten years, Mr. ... which time he advised many of the biotechnology industry,s leading companies. ...
... (NYSE: HAE ) will announce its Q1FY10 earnings on August 3, ... , Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=2323195 ... from August 3, 2009 after 1:00 pm to August 10, 2009. , ... Julie Fallon, Tel. (781) 356-9517, Alt. Tel. ...
Cached Medicine News:Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 2Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 2Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 4Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 5Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 2Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 3Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 4Health News:Schizophrenia Drug Got Bad Rap 2Health News:InteKrin Therapeutics Announces Appointment of Geoffrey M. Parker as Chief Business Officer 2
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Tobramycin Market, 2010-2019" report ... antibiotic whose eye drop and ointment are the most ... or inflammation caused by eye infection. Currently, dozens of ... to produce tobramycin, among which the Top 5 are ...
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Insulin Aspart Market, ... Developed by Novo Nordisk, insulin aspart (under the ... for the treatment of diabetes. Compared with human ... analog, starts working fast and reports higher peak ...
(Date:8/28/2015)... 28, 2015  IP Shakti, LLC, today announced that it ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... new corporate identity signifies our transformation into a company focused ... platform for patent claim validity." ... proprietary AIA Shield™ platform, the Company commenced a corporate re-branding ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... RATON, Fla., Sept. 15 Watermark Medical , ... the sleep-disordered breathing market, has expanded the market reach ... strategic alliances with three leading sleep solution providers in ... SleepQuest , a national provider of comprehensive sleep apnea ...
... Sept. 15 ViroPharma Incorporated (Nasdaq: VPHM ... Phase 1 study of VP20621 (non-toxigenic Clostridium difficile ... Clostridium difficile infections (CDI), a common and dangerous ... of antibiotic medications.  VP20621 contains the spores of a ...
Cached Medicine Technology:Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 2Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 3Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions 4ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 2ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 3ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 4ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 5ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study 6
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
... The first step to treatment is ... is an innovative and quick, patient-friendly tool ... female urinary incontinence while minimizing patient discomfort. ... device features a new type of urethral ...
...
Medicine Products: